Add-on orforglipron improves outcomes in T2D patients on insulin glargine
Daily treatment with oral orforglipron, when added to titrated insulin glargine, has been shown to be beneficial in individuals with inadequately controlled type 2 diabetes (T2D) in the phase 3 ACHIEVE-5 trial.
Sublingual cyclobenzaprine fares well in fibromyalgia
Findings from the phase III RESILIENT study show that a sublingual formulation of cyclobenzaprine (CBP SL) may benefit individuals with fibromyalgia.

MIMS is a trusted, accurate and user-friendly medication information platform. Designed to empower both healthcare professionals and general public to support informed healthcare decisions, our leading drug directory provides clear, reliable information on prescription drugs, over-the-counter medications and other medical resources.

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com